Cours Pharmacyte Biotech Inc Other OTC
Actions
US67090R1005
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2022 | - | CA 2023 | - | Capitalisation | 50,93 M 45,31 M |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -3,56 M | Résultat net 2023 | -4 M -3,56 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 85,4 M 75,97 M | Trésorerie nette 2023 | 68,04 M 60,53 M | VE / CA 2023 | - |
PER 2022 |
-8,53
x | PER 2023 |
-13,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 35,95% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/08/22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/01/15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/08/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/11/22 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/08/22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/12/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+50,70% | 791 Md | |
+41,96% | 630 Md | |
-7,15% | 350 Md | |
+18,77% | 328 Md | |
+8,79% | 298 Md | |
+18,02% | 246 Md | |
+1,27% | 225 Md | |
+11,95% | 218 Md | |
+3,68% | 160 Md |
- Bourse
- Actions
- Action PMCB
- Action